Vipdomet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vipdomet, covering 2025-05-19 to 2025-05-19. Get the full timeline:
Most recent: EMA Authorised: Vipdomet (alogliptin benzoate;metformin hydrochloride) — Takeda Pharma A/S